Royalty Report: Medical, Coating, Device – Collection: 222533

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 18

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 18

Primary Industries

  • Medical
  • Coating
  • Device
  • Chemicals
  • Surgical
  • Delivery
  • Stent
  • Coating surface
  • Tissue
  • Diagnostic
  • Drugs
  • Biotechnology
  • Supply

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 222533

License Grant
Licensor grants to Licensee, a separate worldwide license under Licensor’s Patent Rights and Know-how to make, have made for it only by a properly sublicensed Manufacturer as set forth herein, use, import, and sell that Licensed Product. The license granted herein is expressly limited to the specific Licensed Products defined herein, and does not include the right to sublicense except as set forth.  All licenses granted by Licensor to Licensee under this Agreement are non-exclusive unless specifically stated otherwise for a particular Licensed Product.
License Property
Licensed Products means each of the separately sold Medical Products that bear a Hemocompatable Coating and a Drug Delivery Coating.

Medical Products means the vessel connector and flow-limiter components of a surgically implanted graft prosthetic system for coupling vascular members in the coronary asculature, such as the vessel connector and flow-limiter components of the devices in the illustrations in U.S. Patent 6,241,764 B1.

6,241,764 – Stented grafts for coupling vascular members

Drug-Delivery Coating means chemical compositions comprised of poly(ethylene-co-vinyl acetate) and poly(butyl methacrylate) components for the purpose of releasing Compounds from the chemical composition.

Hemocompatable Coating means chemical coating compositions that contain one or more of the following components photo-reactive polyvinylpyrrolidone copolymer, nonphoto-reactive polyvinylpyrrolidone, photo-reactive heparin, a crosslinking agent known to the parties as PR04, and a compound for promoting polymer-to-metal adhesion and known to the parties as TL03, for the purpose of providing a hemocompatable surface to the Medical Products.

Licensor U.S. Patents

Hemocompatable Coating formulations

1.

METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SOLID SURFACES
U.S. Patent No. 4,973,493 issued 11/27/1990

2.

BIOCOMPATIBLE COATINGS FOR SOLID SURFACES
U.S. Patent No. 4,979,959 issued 12/25/1990

3.

PREPARATION OF POLYMERIC SURFACES VIA COVALENTLY ATTACHING POLYMERS
U.S. Patent No. 5,002,582 issued 3/26/1991

4.

BIOCOMPATIBLE DEVICE WITH COVALENTLY BONDED BIOCOMPATIBLE AGENT
U.S. Patent No. 5,263,992 issued 11/23/1993

5.

SUBSTRATE SURFACE PREPARATION
U.S. Patent No. 5,512,329 issued 4/30/1996

6.

PHOTOACTIVATABLE CROSS-LINKING AGENTS CONTAINING CHARGED GROUPS FOR WATER SOLUBILITY
U.S. Patent No. 6,077,698 issued 06/20/2000

7.

SURFACE COATING AGENTS
U.S. Patent No. 6,278,018 B1 issued 08/21/2001

8.

SURFACE COATING AGENT
U.S. Patent No. 6,603,040B1 issued 8/05/2003

9.

SILANE COATING COMPOSITION
U.S. Patent No. 6,706,408B2 issued 3/16/2004
Drug-Delivery Coating formulations

1.

BIOACTIVE AGENT RELEASE COATING
U.S. Patent No. 6,214,901B1 issued 04/10/2001

2.

BIOACTIVE AGENT RELEASE COATING
U.S. Patent No. 6,344,035B1 issued 02/05/2002

Field of Use
This agreement pertains to coating on medical related devices such as stent.

IPSCIO Record ID: 27987

License Grant
The Company grants to Licensee, a separate worldwide license under the Licensor's Patent Rights and Know-how to make, have made for it by a Manufacturer as defined herein, use and sell that Licensed Product.

The license granted under this Attachment is non-exclusive.

License Property
The Company is engaged in biological, chemical and technical research and has developed a body of technology and know-how, including reagents, processes and devices which the parties believe will improve the performance of various products and processes

“Licensed Products” means Medical Products which are surface-treated with photo-reactive polyvinylpyrrolidone, photo-reactive heparin, diphoto diquat (photo-reactive crosslinking compound) or any combination of these photo-reactive reagents.

“Medical Products” means a single-use, temporary (less than 7 days) catheter placed within the vascular system that is designed, labeled and approved (as may be required by appropriate governmental authority prior to sale) for the purpose of in situ heating or cooling of blood. For the avoidance of doubt, such catheters shall not be designed, labeled or approved for the purpose of infusing or delivering any therapeutic or embolic agents or for the delivery or placement of permanently implantable therapeutic devices (including embolic devices), while the distal tip of such catheter resides at or above the common carotid artery. For purposes of this Attachment B1, saline solutions and contrast media (for placement or diagnostic purposes) are not considered therapeutic agents.

U.S. Patents
1.
METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SOLID SURFACES

U.S.
Patent No. 4,973,493 issued 11/27/90

2.
BIOCOMPATIBLE COATINGS FOR SOLID SURFACES

U.S.
Patent No. 4,979,959 issued 12/25/90

3.
PREPARATION OF POLYMERIC SURFACES VIA COVALENTLY ATTACHING POLYMERS

U.S.
Patent No. 5,002,582 issued 3/26/91

4.
BIOMOLECULE ATTACHMENT TO HYDROPHOBIC SURFACES

U.S.
Patent No. 5,217,492 issued 6/8/93

5.
METHOD OF BIOMOLECULE ATTACHMENT TO HYDROPHOBIC SURFACES

U.S.
Patent No. 5,258,041 issued 11/2/93

6.
BIOCOMPATIBLE DEVICE WITH COVALENTLY BONDED BIOCOMPATIBLE AGENT

U.S.
Patent No. 5,263,992 issued 11/23/93

7.
RESTRAINED MULTIFUNCTIONAL REAGENT FOR SURFACE MODIFICATION

U.S.
Patent No. 5,414,075 issued 5/9/95

8.
SUBSTRATE SURFACE PREPARATION

U.S.
Patent No. 5,512,329 issued 4/30/96

9.
PREPARATION OF CROSSLINKED MATRICES CONTAINING COVALENTLY IMMOBILIZED CHEMICAL SPECIES AND UNBOUND RELEASABLE CHEMICAL SPECIES

U.S.
Patent No. 5,563,056 issued 10/08/96

10.
RESTRAINED MULTIFUNCTIONAL REAGENT FOR SURFACE MODIFICATION

U.S.
Patent No. 5,637,460 issued 6/10/97

11.
PHOTOACTIVATABLE WATER SOLUBLE CROSSLINKING AGENTS CONTAINING AN ONIUM GROUP

U.S.
Patent No. 5,714,360 issued 02/03/98

U.S. Patent Applications
1.
VIRUS INACTIVATING COATINGS

Filed 6/7/95
2.
METHOD AND IMPLANTABLE ARTICLE FOR PROMOTING ENDOTHELIALIZATION

Filed 5/26/95

Foreign Patents
1.
IMPROVEMENT OF THE BIOCOMPATIBILITY OF SOLID SURFACES

Canadian Patent No. 1305068, issued 7/14/92
Australian Patent No. 615637, issued 10/16/87
EPO Patent No. 0326579, issued 1/11/95
2.
BIOMOLECULE ATTACHED TO A SOLID SURFACE BY MEANS OF A SPACER AND METHODS OF ATTACHING BIOMOLECULES TO SURFACES

Canadian Patent No. 1335721, issued 5/30/95

Foreign Patent Applications
1.
BIOCOMPATIBLE COATINGS

Filed in Canada, Europe, Japan, Denmark, and Norway
2.
PREPARATION OF POLYMERIC SURFACES

Filed in Canada, Europe, Japan, Denmark, and Norway
3.
IMMOBILIZATION OF CHEMICAL SPECIES IN CROSSLINKED MATRICES

Filed in Canada, Europe, Australia, Japan
4.
IMPROVEMENT OF THE BIOCOMPATIBILITY OF SOLID SURFACES

Filed in Japan
5.
RESTRAINED MULTIFUNCTIONAL REAGENTS FOR SURFACE MODIFICATION

Filed in Canada, Europe, Australia and Japan

IPSCIO Record ID: 372575

License Grant
Licensor grants a separate worldwide license under Licensors Patent Rights and Know-how to make, have made for it, use, import, have imported, offer for sale and sell that Licensed Product.  The license granted for Atherectomy Catheter is non-exclusive.
License Property
Licensor is engaged in biological, chemical and technical research and has developed a body of technology and know-how including reagents, processes and devices.

The patents are Latent Reactive Chemical Patents.

The Licensed Products means each of the separately sold Medical Products.

Medical Products means a catheter that is specifically designed and labeled to excise stenotic, sclerotic materials from the coronary vascular and peripheral vascular systems.

Licensed Products means Medical Products which are surface-treated with photo-reactive polyacrylamide, photo-reactive polyvinylpyrrolidone, tetrabenzoylbenzyl ether or diphotodiquat, latent-reactive crosslinking compounds, or any combination of these photo-reactive reagents.

U.S. Patents
1. METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SOLID SURFACES
U.S. Patent No. 4,973,493

2. BIOCOMPATIBLE COATINGS FOR SOLID SURFACES

U.S. Patent No. 4,979,959
3. PREPARATION OF POLYMERIC SURFACES VIA COVALENTLY ATTACHING POLYMERS
U.S. Patent No. 5,002,582

4. BIOMOLECULE ATTACHMENT TO HYDROPHOBIC SURFACES
U.S. Patent No. 5,217,492

5. METHOD OF BIOMOLECULE ATTACHMENT TO HYDROPHOBIC SURFACES
U.S. Patent No. 5,258,041

6. BIOCOMPATIBLE DEVICE WITH COVALENTLY BONDED BIOCOMPATIBLE AGENT
U.S. Patent No. 5,263,992

7. RESTRAINED MULTIFUNCTIONAL REAGENT FOR SURFACE MODIFICATION
U.S. Patent No. 5,414,075

8. SUBSTRATE SURFACE PREPARATION
U.S. Patent No. 5,512,329

9. PREPARATION OF CROSSLINKED MATRICES CONTAINING COVALENTLY IMMOBILIZED CHEMICAL SPECIES AND UNBOUND RELEASABLE CHEMICAL SPECIES
U.S. Patent No. 5,563,056

10. RESTRAINED MULTIFUNCTIONAL REAGENT FOR SURFACE MODIFICATION
U.S. Patent No. 5,637,460

11. PHOTOACTIV A TABLE WATER SOLUBLE CROSSLINKING AGENTS CONTAINING AN ONIUM GROUP
U.S. Patent No. 5,714,360

Field of Use
The master license agreement is for the right to coat catheters with certain proprietary coating materials.

IPSCIO Record ID: 203473

License Grant
Licensor grants to Licensee a world-wide license under the Licensors Patent Rights and the Licensor Licensed Technology, to make, have made for it, use, sell, or import into the United States, the Licensed Products. The license granted herein is exclusive under the patent rights with respect to the exclusive products and non-exclusive with respect to the non-exclusive products.  The license granted herein does not include the right to sublicense and is expressly limited to the specific licensed products defined herein.
License Property
1. United States Patent No . 6,214,901 Bl to Chudzik et al, issued April 10, 2001, titled Bioactive agent release coating

2. United States Patent No . 6,344,035 Bl to Chudzik et al, issued February 5, 2002, titled Bioactive agent release coating

3. United States Patent Application Ser. No. **10/175, 212, FILED 6/1 8/02, Titled Method and System for providing Bioacive agent release coating

4. United States Patent Application Ser. No . **10/174, 635, FILED 6/18/02, Titled Bioactive agent release coating with aromatic poly (meth) acrylates

5. United States Patent Application Ser. No . **10/17 5, 2 10, FILED 6/18/02, Titled Bioactive agent release coating and controlled humidity method

6. United States Patent Application Ser . No . **09/98 9, 033, FILED 11/21/01, Titled Bioactive agent release coating, Publ.  U. S. 20020032434**

7. United States Patent Application Ser. No . * *10/ ___ FILED 10/10/02,Titled Bioactive agent release coating

8. United States Patent Application Ser . No . ** 10/ ___ , FILED 12/6/02, Titled Barriers for polymeric coatings

Licensor Licensed Technology means those items described, including, to the extent those items that were not known to the public at the time of their disclosure by Licensor to Licensee.
Supplier of PEVA/ PBMA
Purification Solvents
Purification process (if obtained from escrow)
Initiator/catalyst
Additive detection methods
Polymer purification equipment
Receiving inspection procedures for PEVA, PBMA
CP02 ( PEVA) Specification
CPOl (PBMA) Specification
PEVA and CP02 Test Requirements
PBMA and CPOl Test Requirements

Field of Use
This agreement pertains to the medical industry relating to coating composition for use in coating implantable medical devices.

IPSCIO Record ID: 203456

License Grant
Attached to this settlement agreement, the Licensor grants a worldwide non-exclusive license under Licensors Patent Rights and Know-how to make, have made for it, use, and sell Licensed Products. The license granted herein is expressly limited to the specific Licensed Products defined herein, and does not include the right to sublicense except to an Affiliate.

This license granted for Laser Angioplasty Catheters is non-cancelable by Licensee during the period from the Effective Date through June 30, 2009.

This license granted for Non-Laser Functioning Catheters and Guidewires for use with Licensees Laser Therapy Systems is non-exclusive.

License Property
The licensors patents include, but are not limited to, Method of Improving the Biocompatibility of Solid Surfaces, Surface Coating Agents and Substrate Surface Preparation.

The Licensed Products means Medical Products that are surface-treated with photoreactive polyvinylpyrrolidone copolymer, non-photoreactive polyvinylpyrrolidone, photoreactive polyacrylamide copolymer, one or more of the photoreactive crosslinking agents known to the parties as PR01 and PR04, a compound for promoting polymer-to-metal adhesion known to the parties as TL03, or any combination of these compounds, for the purpose of providing a lubricious surface to the Medical Products.

MEDICAL PRODUCTS-B1 Laser Angioplasty Catheters
The Medical Products means excimer laser angioplasty catheters specifically adapted for coronary and peripheral use. Medical Products includes Licensees chronic total occlusion laser angioplasty catheters.

MEDICAL PRODUCTS-B2 Non-Laser Functioning Catheters and Guidewires for use with Spectranetics Laser Therapy Systems
The Medical Products means the following Licensee-labeled non-laser functioning catheters and guidewires for Licensees laser therapy system that are specifically designed and labeled for use solely with laser angioplasty catheters (I) BIAS sheath, (ii) support catheters, (iii) cardiac lead locking device, and (iv) chronic total occlusion steerwires.  Medical Products does not include catheters for (I) infusion of diagnostic, therapeutic, or embolic agents in the neurovascular region, or (ii) insertion of therapeutic embolic devices in the neurovascular region. Medical Products does not include catheters used to deliver stents of any type.

Field of Use
Licensee designs, manufactures, markets and distributes single-use medical devices used in minimally invasive surgical procedures within the vascular system in conjunction with our proprietary excimer laser system.

IPSCIO Record ID: 5512

License Grant
The Licensor hereby grants to the Licensee the exclusive worldwide license for certain patented technologies marketed under the trade names PROstent (TM) and Liprostin / PROstent (TM), and the Licensor's referenced technologies with multiple stent coating applications for use with other medical devices, including catheter delivery of PROstent.
License Property
The technology being licensed includes Patent Application No. 09/309,949; Filed on May 11, 1999; 'Prosthesis With Biodegradable Surface Coating and Method For Making Same.' This application is a continuation-in-part application of U.S. Patent Application Serial No. 08/797,743 filed on February 7, 1997.
Abstact A vascular structure includes suitable mechanical properties needed to open and maintain a vessel, duct, tract, or organ and precise chronicity controlling the release and delivery of a bioactive agent carried on the vascular structure. The bioactive agent is capable of acting upon and altering the mechanisms of biologic systems in a manner providing a medicinal therapy. The vascular structure includes at least one layer or coating of the bioactive agent overlaid by a permiable membrane for controlling the osmotic release of the bioactive agent.

Technology also includes Patent Application Serial No. 08/797,743; Filed on February 7, 1997; 'Composition and Method For Making a Biodegradable Drug Delivery Stent'.  Licensee is from Canada and licensor from U.S.
Abstract A stent or vascular graft for supporting a blood vessel or organ lumen is coated with a biodegradable, resorbable and hemocompatible surface substrate. Biologically active microspheres which controllably release the biologically active agent into the vessel wall or organ to inhibit restenosis of the stent is embedded in the stent substrate. The biologically active microspheres include encapsulated PGE1 in a water soluble polyethylene glycol mix, which over a period of time dissolves and releases the PGE1 into the vessel wall or organ.

USE OF TRADEMARKS. The Licensee will be allowed to use any and all trademarks of the Licensor with respect to the Technology, Products and any Improvements.

IPSCIO Record ID: 109

License Grant
The Licensor grants the Licensee, a separate non-exclusive, worldwide License under the Patent Rights and Know-how to make, use, and sell that Licensed Product. The License does not include the right to subLicense and shall extend until expiration of the last to expire patent of Patent Rights that covers that product or for a period of fifteen years from the Licensed Product effective date, whichever is longer.
License Property
The Licensor is engaged in research and has developed a body of technology and know-how relating to the surface treatment of medical devices, including chemical compositions, processes, and equipment which the parties believe will improve the performance of various products and processes of CARDIMA.

U.S. Patents
1.   METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SOLID SURFACES
U.S. Patent No. 4,973,493 issued 11/27/1990
2.   BIOCOMPATIBLE COATINGS FOR SOLID SURFACES
U.S. Patent No. 4,979,959 issued 12/25/1990
3.   PREPARATION OF POLYMERIC SURFACES VIA COVALENTLY ATTACHING POLYMERS
U.S. Patent No. 5,002,582 issued 3/26/1991
4.   BIOCOMPATIBLE DEVICE WITH COVALENTLY BONDED BIOCOMPATIBLE AGENT
U.S. Patent No. 5,263,992 issued 11/23/1993
5.   RESTRAINED MULTIFUNCTIONAL REAGENT FOR SURFACE MODIFICATION
U.S. Patent No. 5,414,075 issued 5/9/1995
6.   SUBSTRATE SURFACE PREPARATION
U.S. Patent No. 5,512,329 issued 4/30/1996
7.   RESTRAINED MULTIFUNCTIONAL REAGENT FOR SURFACE MODIFICATION
U.S. Patent No. 5,637,460 issued 6/10/1997
8.   PHOTOACTIVATABLE WATER SOLUBLE CROSSLINKING AGENTS CONTAINING AN ONIUM GROUP
U.S. Patent No. 5,714,360 issued 02/03/1998
9.   PHOTOACTIVATABLE CROSS-LINKING AGENTS CONTAINING CHARGED GROUPS FOR WATER SOLUBILITY
U.S. Patent No. 6,077,698 issued 06/20/2000
10.   SURFACE COATING AGENTS
U.S. Patent No. 6,278,018 B1 issued 08/21/2001
11.   SURFACE COATING AGENTS
U.S. Patent No. 6,603,040 B1 issued 8/5/2003  

Foreign Equivalents

US 4979959 WO 8802623     Application
US 5263992 Designated States (National) AU DK JP NO
   Designated States (Regional) AT BE CH DE FR GB IT LU NL SE
   JP 2981488     Issued
   Div ex application JP 87506895
   Previous Publ. patent JP 10179726
   EP 326579       Application
   Designated States (Regional) AT BE CH DE FR GB IT LI LU NL SE
   EP 326579       Issued
   Based on patent WO 8802623
   Designated States (Regional) AT BE CH DE FR GB IT LI LU NL SE
   DE 3750989      Issued
   Based on patent EP 326579
   Based on patent WO 8802623
   JP 2741378     Issued
   Previous Publ. patent JP 2500250
   Based on patent WO 8802623
   JP 10179726 Application
   Div ex application JP 87506895
   CA 1305068     Issued
US 5512329 WO 9000887      Application
US 4973493 Designated States (National) DK JP NO
US 5002582 Designated States (Regional) AT BE CH DE FR GB IT LU NL SE
   EP 425485       Application
   Designated States (Regional) AT BE CH DE FR GB IT LI LU NL SE
   JP 2855224    Issued
   Previous Publ. patent JP 3505979
   Based on patent WO 9000887
   CA 1340345       Issued
   EP 425485       Issued
   Based on patent WO 9000887
   Designated States (Regional) AT BE CH DE FR GB IT LI LU NL SE
   DE 3856430     Issued
   Based on patent EP 425485
   Based on patent WO 9000887
US 5414075 WO 9411032
US 5637460 Designated States (National) AU CA JP
   Designated States (Regional) AT BE CH DE DK ES FR GB GR IE IT LU MC NL
   PT SE
   AU 9454567 Application
   Based on patent WO 9411032
   EP 669837      Application
   Based on patent WO 9411032

   Designated States (Regional) AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
   JP 8505839       Application
   Based on patent WO 9411032
   AU 688286
   Previous Publ. patent AU 9454567
   Based on patent WO 9411032
   CA 2148801        Patent
   Based on patent WO 9411032
   EP 669837       Patent
   Based on patent WO 9411032
   Designated States (Regional) AT BE CH DE DK ES FR GB GR IE IT LI LU MC
   NL PT SE
   DE 69332858 Application
   Based on patent EP 669837
   Based on patent WO 9411032
   ES 2196011       Application
   Based on patent EP 669837
US 5714360 A WO 9716544
US 6077698 A Designated States (National) AU CA JP MX
Cont of Designated States (Regional) AT BE CH DE DK ES Fl FR GB GR IE IT LU
application MC NL PT SE
US    
95552758 AU 9675531
   Based on patent WO 9716544
Cont of patent US EP 862624
5714360 Designated States (Regional) DE ES FR GB IT
   JP 2000500440 W
   Based on patent WO 9716544
   AU 731249
   Previous Publ. patent AU 9675531            
Based on patent WO 9716544
   MX 9803444
   EP 862624
   Based on patent WO 9716544
   Designated States (Regional) DE ES FR GB IT
   DE 69632541
   Based on patent EP 862624
   Based on patent WO 9716544
   CA 2236588
   Based on patent WO 9716544
US 6278018 WO 200144174 Application
    US 6603040  Designated States (National) AE AG AL AM AT AU AZ BA BB BG BR BY BZ
CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL
IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW
MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US
UZ VN YU ZA ZW
Designated States (Regoinal) AT BE CH CY DE DK EA ES FI FR GB GH GM GR
IE IT KE LS LU MC MW MZ NL OA PT SD SE SL SZ TR TZ UG ZW
AU 200119593
Application Based on patent WO 200144174
EP 1250319 Application
JP 2003517083 Application
Based on patent WO 200144174 MX 2002005858
Application Based on patent WO 200144174
US 20040030159 Application

Field of Use
Licensed Products means Medical Products that are surface-treated with photoreactive polyvinylpyrrolidone copolymer and non-photoreactive polyvinylpyrrolidone, and may contain one or more of the photoreactive crosslinking agents known to the parties as PRO1, PRO3, and PRO4, or any combination of these compounds, for the purpose of providing a lubricious surface to the Medical Products.

IPSCIO Record ID: 117

License Grant
Licensor hereby grants Licensee a revertible exclusive license (even to the exclusion of Licensor) to make, have made, use, sell, offer for sale and import Products in the Territory under certain Patent Rights limited to any new patents granted to Licensor for radiopaque polymer coatings and the Know-How required in Licensor's discretion, to practice these certain Patent Rights licensed hereunder. Licensor also grants a non-exclusive license to make, have made, use, sell, offer for sale and import Products in the Territory under certain Patent Rights for patents 4,642,267 and 4,769,013 limited to use on or with radiopaque coatings excluding any use for drug delivery and the Know-How required in Licensor's discretion, to practice these certain Patent Rights licensed hereunder. The rights licensed are collectively referred to as Licensed Patent Rights.
Field of Use
Products means Class 1 intravascular stents for arterial use in humans coated with a radiopaque polymer coating using the Patent Rights and  Class 2 peripheral stents for use in and around the human heart coated with a radiopaque polymer coating using the Patent Rights.

IPSCIO Record ID: 25882

License Grant
The German Licensee was granted a License by the Licensor to use the patents and technology for coatings comprising hydrophilic polymers used to immobilize molecules and other materials for the purpose of microarraying and to make, use, sell, offer to sell, import and export the Licensed Product on a non-exclusive basis.
License Property
OptiChem(r) surface coatings and assay processing methods. We believe that OptiChem coatings within the sample distribution flow passages will prevent most bacteria from adhering to the passage walls. We believe that applying OptiChem coatings to such devices might significantly reduce bacterial loss during specimen preparation.

Hydrogel Coatings means coatings comprising hydrophilic polymers used to immobilize molecules and other materials for the purpose of microarraying.

United States Patent Application
Title Functional Surface Coating  Publication Number US 2004/0115721 A1  Publication Date June 17, 2004

International Application Published Under the Patent Cooperation Treaty (PCT)
Title Functional Surface Coating  Publication Number WO 03/000433 A1  Publication Date January 3, 2003

United States Provisional Patent Application
Title Composition and Method of Forming a Functional Coating  Date of Deposit April 10, 2004

United States Patent
Title Functional Surface Coating  Publication Number US 6,844,028 B2  Publication Date Jan 18, 2005

United States Patent
Title Functional Surface Coating  Publication Number US 7,067,194 B2  Publication Date Jun 27, 2006

Field of Use
The rights granted apply to surface coatings for the purpose of microarraying preventing bacteria from adhering to passage walls.

IPSCIO Record ID: 2168

License Grant
The Licensor grants to Licensee (ii) an exclusive license, under all proprietary rights existing on the effective date, with right to sublicense, to manufacture or have manufactured, throughout the territory, Superslip Coating, Biostatic Coating and Stay Wet Coating solely for the Licensed Application, (ii) an exclusive license, throughout the Territory, under all Proprietary Rights existing on the Effective Date, with right to sublicense, to apply (or have applied) Superslip Coating, Biostatic Coating and Stay Wet Coating to all products within the Licensed Application, (iii) an exclusive license, throughout the Territory, under all Proprietary Rights existing on the Effective Date, with right to sublicense, to use, sell, offer for sale, import and export all Product.
License Property
Product means any product within the Licensed Application which is coated with Superslip Coating, Biostatic Coating or Stay Wet Coating

Proprietary Rights -means all applications for Letters Patent, issued Letters Patent (including but not limited to United States Letters Patent No. 4,642,267).

Field of Use
Licensed Application means intermittent and indwelling urological catheters.

IPSCIO Record ID: 222532

License Grant
The purpose of this amendment is to (i) transfer the rights and obligations of Party A to Party C, (ii) amend the royalty payment provision set forth in the Agreement, and (iii) amend the termination provision set forth in the Agreement.

Accordingly, this letter confirms the assignment of the rights and obligations of Party A to Party C and acknowledges the consent thereto by Party B.

License Property
Royalty Obligations means Net Sales” means the gross amount received on the sale of Royalty Products by Licensee.

Royalty Product means a product developed and sold by Party C that is covered by a Valid Claim of an Unexpired patent that is included within the Patent Rights.

Patent Right or Patent Rights means (x) U.S. Patent No. 6,241,761 (Stented Grafts for Coupling Vascular Members) issued on June 5, 2001, and U.S. Patent No. 6,241,764 (Stented Grafts Coupling Vascular Members) issued on June 5, 2001 (including any divisions, continuations, reexaminations, reissue substitution applications thereof and foreign applications based thereon) and (y) any and all patents issuing therefrom and extensions thereof.

Field of Use
This agreement pertains to the medical industry relating to stented grafts for coupling vascular members.

IPSCIO Record ID: 369243

License Grant
For the CoSeal Sealant Units Exclusive Distribution, Sales and Marketing Rights,  Licensors of the United States, Switzerland and Canada grant
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in the Sealant Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in the Sealant Territory during the term of this Distribution and License Agreement.

For the CoSeal Sealant Option, Licensor grants an option (the CoSeal Sealant Option)
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in Japan; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in Japan.

For the CoSeal Adhesion Prevention Units Exclusive Distribution, Sales and Marketing Rights, Licensor grants
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the Adhesion Prevention Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the Adhesion Prevention Territory during the term of this Distribution and License Agreement.

For the CoSeal Adhesion Prevention Option, Licensor grants to an option (the CoSeal Adhesion Prevention Option)
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the United States; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the United States.

For the CoSeal Accessories Exclusive Rights, Licensor grants
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Accessories in the Field in the Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import the CoSeal Accessories in the Field in the Territory.

License Property
The trademarks include COSEAL©, ADHIBIT™, and, ANGIOTECHKNOWLEDGY™.

CoSeal Ingredients shall mean the two derivatized polyethylene glycol ingredients, designated COH102 and COH206

CoSeal Adhesion Prevention Unit shall mean a CoSeal Adhesion Prevention Product sold in combination with a CoSeal Adhesion Prevention Device.

CoSeal Devices shall mean, collectively, as the context requires, both or either of the CoSeal Adhesion Prevention Devices and/or the CoSeal Sealant Devices.

CoSeal Unit shall mean, collectively, as the context requires, both or either of the CoSeal Sealant Unit and/or the CoSeal Adhesion Prevention Unit.

CoSeal Sealant Unit shall mean a CoSeal Sealant Product sold in combination with a CoSeal Sealant Device.

CoSeal Sealant Product shall mean a product containing the CoSeal Ingredients that is the subject matter of a Regulatory Filing for use as a tissue sealant, adhesive or glue, has been or is approved by one or more Regulatory Authorities for use as a tissue sealant, adhesive or glue, or that is in development or sold for use as a tissue sealant, adhesive or glue.

Field of Use
CoSeal is indicated for use in vascular reconstructions to achieve adjunctive ·hemostasis by mechanically sealing areas of leakage.  CoSeal is designed to rapidly seal tissue surfaces, suture lines and synthetic grafts during surgery.

Field shall mean human therapeutic use for any and all tissue sealing, adhesive, glue or adhesion prevention barrier indications but shall specifically exclude any use (i) in Hemostat indications; (ii) for tissue regeneration indications; (iii) as an osteobiologic for skeletal repair an non-pharmacologic devices for osteoarthritis treatment,; (iv) as a urinary incontinence product and for the treatment of urinary incontinence; or (v) as an ostomy product.

IPSCIO Record ID: 209508

License Grant
Licensor, of the Netherlands, grants a non-exclusive, worldwide license to import, export, use, sell, and offer for sale Licensees Stents utilizing, incorporating or coated with Licensors Drug/Polymer Composite Formulation, Biolimus A9 and/or Licensors Polymer Coating in Licensees Licensed Field of Use; and

At Licensees option, a non-exclusive, worldwide license to import, export, use, sell, and offer for sale Licensee Stent Systems incorporating or utilizing Licensors Lubricious Coating.

License Property
The Coated Stents means Licensees Stents marketed, developed or sold by Licensee and coated with Licensors Polymer Coating, Occams Drug/Polymer Composite Formulation, or Biolimus A9.

The Covered Products means either or both Coated Stents and Licensee Stent Systems incorporating or utilizing Licensors Lubricious Coating.

The patents relate to Endovascular Stents and coatings.

Biolimus A9 is formulated to inhibit excessive tissue formation around the stent following implantation, a common side effect called restenosis which often threatens to reverse the clinical benefits of the angioplasty and stent implantation procedures.

Field of Use
Licensees Licensed Field of Use means any applications, procedures, processes or other uses related to drug-eluting, commonly delivered Stents that are delivered as a series of short stents on a delivery catheter wherein the operator has the ability to select the number of short stents as a portion of the total number of stents in the series to be deployed, solely for use in coronary and peripheral vascular applications.

In Japan, Licensees Licensed Field of Use is further limited to treating long lesions, multiple vessels or small vessels in coronary and peripheral applications.

IPSCIO Record ID: 669

License Grant
Licensor hereby grants Licensee its Affiliates an exclusive, worldwide, sublicensable license in and to Licensor’s IP to (i) use, make, have made, sell, offer to sell, import, modify, distribute, perform and otherwise exploit the Exclusive Products and (ii) enforce such Licensor’s IP against other Persons and collect past, present and future damages from any other Person’s infringement or misappropriation of Licensor’s IP but all of the foregoing rights and licenses are limited to the Field.
License Property
“Non-Drug Coated” means devices not coated with a drug or a drug eluting polymer coating.  Exclusive Product/Services  Vascular stents including coronary, neuro or peripheral applications of coated or uncoated stents; Embolic protection devices, aneurysm coils and all other vascular implants (other than stents); RF ablation probes and ablation fluid.

Non-Exclusive Product/Services Biopsy needles, including aspiration, cutting needles and breast localization needles; Interventional guidewires (for use in all applications); Interventional vascular catheters (<6 hours), including PTCA, predilation, etc.; Indwelling vascular catheters (>6 hours), including CVC, PICC, etc.; Pacemakers, including leads; Implantable cardiac defibrillators and related devices, including their leads; Auditory implants, e.g. cochlear implants; Neuro stimulation including deep brain.

Field of Use
“Field” means systems, devices, components, compositions and processes for magnetic resonance imaging, including without limitation for providing or enhancing (a) safety, effectiveness, image quality and/or image compatibility or (b) the visualization of medical devices in vivo.

IPSCIO Record ID: 588

License Grant
The Licensor granted to the Licensee a non-exclusive License under the Licensed Patents to the Coating in order for the Licensee to make, have made, import, offer for sale, sell and use Coated Products for medical use in the territory.  The Licensor also granted to the Licensee the right to use the Licensed Marks in connection with Coated Products.
License Property
Licensed Marks means the marks STS and Slip-Coat as used in connection with marketing, promotion, and labeling of Licensed Products and related services, including marks which are registered in any country and marks acquired by usage and common law rights.

Licensed Patents means United States Patent Nos. 5,001,009, 5,069,899, 5,331,027, their foreign counterparts, patent applications on which such patents are based, and any division, continuation, continuation-in-part, reissue or extension thereof.

Field of Use
The rights granted apply for medical use.

IPSCIO Record ID: 27977

License Grant
The Canadian University grants to the Licensee an exclusive worldwide license to use and sublicense the Technology and any Improvements within the Field of Use and to manufacture, distribute and sell the Products within the Field of Use on the terms and conditions set out in this Agreement.
License Property
US Patent Application No.  09/838,331 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation.

University will provide the Hydroxyapatite coatings which are to be applied on stents to be provided by the Licensee.

Field of Use
'FIELD OF USE' means the Technology and any Improvements will be used to produce hydroxyapatite and related calcium phosphate compounds on medical devices and on scaffolding, wherein 'scaffolding' means stents, gauze, wires, wire mesh, films or microscale particles. For greater certainty, the Field of Use shall not include any use of the Technology or Improvements to produce hydroxyapatite and related calcium phosphate compounds on or for orthopaedic implantables, trauma fixation devices, dental implants and bone substitutes.

IPSCIO Record ID: 299236

License Grant
Under the initial agreement, the Canadian Licensor agreed to license on a co-exclusive certain patent rights, license rights, and technology.

This agreement is extending Licensee’s worldwide right and license to use, manufacture, have manufactured, distribute and sell, and to grant sublicenses to its Affiliates to use, manufacture, have manufactured, distribute and sell, the Licensor Technology in the Peripheral Vascular Field of Use and the GI Field of Use.

Licensor newly grants its licensee, the right for Licensee to have third party Distributors distribute Eligible Peripheral Vascular and/or GI Products.

This agreement is co-exclusive with an option to become exclusive.

License Property
This agreement is for paclitaxel or certain other agents as a coating for certain medical devices.

The license agreement regards paclitaxel-eluting stent products and related technologies.  Paclitaxel is released from the balloon or stent to prevent scar tissue formation in the blood vessel that can re-obstruct the artery (restenosis).

Field of Use
As used herein, the Coronary Vascular Field of Use means endoluminal vascular Licensed Applications for the treatment and/or prevention of disease of the coronary arteries and their branches, or other vasculature providing blood flow to the heart.

As used herein, the Peripheral Vascular Field of Use means the endoluminal vascular licensed applications for the treatment or preventionof disease of the peripheral blood vessels of the body.  Notwithstanding the foregoing, Peripheral Vascular Field of Use excludes any application in the Coronary Vascular Field of Use.  

GI Field of Use means the endoluminal licensed applications for the treatment or prevention of disease of the alimentary tract or liver.

IPSCIO Record ID: 5753

License Grant
Licensor hereby grants to Implant a perpetual, worldwide, royalty free license to use any and all technology specifically developed by Licensor for use in the manufacture or coating of the Stents. Licensor hereby agrees to execute and deliver any and all additional documentation Implant reasonably deems necessary or desirable to transfer to Implant the rights set forth in this agreement.
License Property
The parties hereto desire to develop polymer covered or coated vascular stents utilizing proprietary technologies of each party.

The parties agree that upon completion of the research and development contemplated by this Agreement, they will negotiate and enter into an agreement pursuant to which the Licensee will have the exclusive right to manufacture and sell the Stents.

Field of Use
The rights granted relate to vascular stents.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.